Preparation for recuperating pancreatic cancer of patients in oncology department under medical treatment and preparation method thereof

Abstract

The invention discloses a preparation for recuperating pancreatic cancer of patients in oncology department under medical treatment. The preparation method is prepared from the following raw medicinal materials in parts by mass: 7 to 12 parts of rhizoma polygoni cuspidati, 9 to 13 parts of flos citri sarcodactylis, 6 to 14 parts of caudate sweetleaf root, 4 to 10 parts of leaf or root of Littlefruit Uvaria, 3 to 7 parts of herba hyperici japonica, 6 to 12 parts of oxalis corymbosa, 5 to 9 parts of flos rosae rugosae, 3 to 6 parts of water chestnut, 7 to 10 parts of Chinaroot Greenbier Rhizome, 4 to 9 parts of dry moss, 6 to 10 parts of egg shell of mulberry silkworm, 8 to 12 parts of radix sophorae tonkinensis, 5 to 11 parts of seed of garden balsam, 3 to 8 parts of Amorphophallus virosus N.E.Browu, and 6 to 9 parts of herba drcocephali integrifolii. The preparation disclosed by the invention is wide in medicinal herbs resource, low in cost and applicable to long-term use, and does not bring an economic burden for the patients; the formula of the preparation is obtained according to principles of traditional Chinese medicine and several years of clinical experiences, and has equal efficacies. The preparation is stable in curative effect, and has the capabilities of resisting cancers and removing qi stagnation, effectively restricting diffusion of cancer cells and retarding the development of illness states.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a preparation and a preparation method for postoperative treatment of pancreatic cancer in oncology patients. Background technique [0002] Pancreatic cancer is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. About 90% of pancreatic cancers are ductal adenocarcinomas originating from the ductal epithelium. Its morbidity and mortality have increased significantly in recent years. The 5-year survival rate is <1%, and it is one of the malignant tumors with the worst prognosis. The pathogenic factors of pancreatic cancer are still unclear, and the proportion of pancreatic cancer in people with chronic pancreatitis and diabetes is higher than that in normal people. Smokers are more than three times more likely to develop pancreatic cancer than non-smokers. "Three high" diet, that is, high-protein, high-fat, and high-calorie foo...

AI Technical Summary

Problems solved by technology

[0004] At present, the clinical treatment of pancreatic cancer is mainly based on radiotherapy, chemotherapy and surgery, both of which will cause irreversible damage to patients, and the curative effect is not high, and at the same time cause great economic pressure on patients. Therefore, a comprehensive method combining Chinese and Western medicine can be used to treat pancreatic cancer Patient treatment to relieve suffering and improve quality of life